Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 7
2004 4
2005 5
2006 7
2007 6
2008 5
2009 5
2010 3
2011 2
2012 1
2013 1
2014 1
2016 1
2017 1
2021 1
2022 1
2023 1
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Safety and Effectiveness of Sutimlimab in Cold Agglutinin Disease: A Real-World International Experience.
Fattizzo B, Sambruna E, Miyakawa Y, Michel M, Visco C, Fillitz M, Kannourakis G, Greve MB, Kleemiss M, Cid J, Patriarca A, Pavan L, Dizdari A, Maschio N, Sau A, Bitetti C, Colombo RM, Curreli L, Lame D, Markovic U, Pappagallo F, Pedone GL, Rapezzi D, Sammartano V, Tumedei N, Solimando AG, Marit J, Fianchi L, Khwaja J, De Vivo A, Lanza F, Vianello F, Oliva EN, Broome C, Passamonti F, Jaeger U, Jilma B, Moulis G, Barcellini W. Fattizzo B, et al. Among authors: de vivo a. Am J Hematol. 2026 Apr 16. doi: 10.1002/ajh.70307. Online ahead of print. Am J Hematol. 2026. PMID: 41991255
Real life use of ravulizumab in Italian patients with paroxysmal nocturnal hemoglobinuria: evidence from the REACTION observational study.
Iori AP, De Vivo A, Di Bona E, Caocci G, Fioritoni F, Ciceri F, Beggiato E, Rapezzi D, Amendola A, Figuera A, Selleri C, Longu F, Fattizzo B, Tucci A, Cignetti A, Amico V, Sica S, Metafuni E, Raso S, Urbano TA, Marano L, Di Renzo N, Spedini P, Rambaldi A, Lanza F, Clissa C, Danesin C, Greve MB, Cabibbo S, Ori A, Cassanelli F, Sottana F, Campolo B, Gasparri G, Carini F, Barcellini W. Iori AP, et al. Among authors: de vivo a. Ann Hematol. 2026 Jan 22;105(2):50. doi: 10.1007/s00277-026-06792-w. Ann Hematol. 2026. PMID: 41566054 Free PMC article.
Management of infection in PNH patients treated with eculizumab or other complement inhibitors: Unmet clinical needs.
Girmenia C, Barcellini W, Bianchi P, Di Bona E, Iori AP, Notaro R, Sica S, Zanella A, De Vivo A, Barosi G, Risitano A; scientific committee of the Associazione Italiana Emoglobinuria Parossistica Notturna (AIEPN). Girmenia C, et al. Among authors: de vivo a. Blood Rev. 2023 Mar;58:101013. doi: 10.1016/j.blre.2022.101013. Epub 2022 Sep 6. Blood Rev. 2023. PMID: 36117056 Review.
Molecular response and quality of life in chronic myeloid leukemia patients treated with intermittent TKIs: First interim analysis of OPTkIMA study.
Malagola M, Iurlo A, Abruzzese E, Bonifacio M, Stagno F, Binotto G, D'Adda M, Lunghi M, Crugnola M, Ferrari ML, Lunghi F, Castagnetti F, Rosti G, Lemoli RM, Sancetta R, Coppi MR, Corsetti MT, Rege Cambrin G, Romano A, Tiribelli M, Russo Rossi A, Russo S, Aprile L, Bocchia M, Gandolfi L, Farina M, Bernardi S, Polverelli N, Roccaro AM, De Vivo A, Baccarani M, Russo D. Malagola M, et al. Among authors: de vivo a. Cancer Med. 2021 Mar;10(5):1726-1737. doi: 10.1002/cam4.3778. Epub 2021 Feb 16. Cancer Med. 2021. PMID: 33594821 Free PMC article. Clinical Trial.
A population-based study of chronic myeloid leukemia patients treated with imatinib in first line.
Castagnetti F, Di Raimondo F, De Vivo A, Spitaleri A, Gugliotta G, Fabbiano F, Capodanno I, Mannina D, Salvucci M, Antolino A, Marasca R, Musso M, Crugnola M, Impera S, Trabacchi E, Musolino C, Cavazzini F, Mineo G, Tosi P, Tomaselli C, Rizzo M, Siragusa S, Fogli M, Ragionieri R, Zironi A, Soverini S, Martinelli G, Cavo M, Vigneri P, Stagno F, Rosti G, Baccarani M. Castagnetti F, et al. Among authors: de vivo a. Am J Hematol. 2017 Jan;92(1):82-87. doi: 10.1002/ajh.24591. Epub 2016 Nov 18. Am J Hematol. 2017. PMID: 27770583 Free article.
Long term outcome of Ph+ CML patients achieving complete cytogenetic remission with interferon based therapy moving from interferon to imatinib era.
Malagola M, Breccia M, Skert C, Cancelli V, Soverini S, Iacobucci I, Cattina F, Liberati AM, Tiribelli M, Annunziata M, Trabacchi E, De Vivo A, Castagnetti F, Martinelli G, Fogli M, Stagno F, Pica G, Iurlo A, Pregno P, Abruzzese E, Pardini S, Bocchia M, Russo S, Pierri I, Lunghi M, Barulli S, Merante S, Mandelli F, Alimena G, Rosti G, Baccarani M, Russo D. Malagola M, et al. Among authors: de vivo a. Am J Hematol. 2014 Feb;89(2):119-24. doi: 10.1002/ajh.23593. Am J Hematol. 2014. PMID: 24122886 Free article.
Effects and outcome of a policy of intermittent imatinib treatment in elderly patients with chronic myeloid leukemia.
Russo D, Martinelli G, Malagola M, Skert C, Soverini S, Iacobucci I, De Vivo A, Testoni N, Castagnetti F, Gugliotta G, Turri D, Bergamaschi M, Pregno P, Pungolino E, Stagno F, Breccia M, Martino B, Intermesoli T, Fava C, Abruzzese E, Tiribelli M, Bigazzi C, Cesana BM, Rosti G, Baccarani M. Russo D, et al. Among authors: de vivo a. Blood. 2013 Jun 27;121(26):5138-44. doi: 10.1182/blood-2013-01-480194. Epub 2013 May 15. Blood. 2013. PMID: 23678005 Free article. Clinical Trial.
The influence of planned kinds of delivery on pregnant women's emotional state.
Giacobbe A, Maggio Savasta L, De Dominici R, De Vivo A, Giacobbe V, Grasso R, Triolo O, Mancuso A. Giacobbe A, et al. Among authors: de vivo a. J Matern Fetal Neonatal Med. 2012 Jul;25(7):1188-90. doi: 10.3109/14767058.2011.600794. Epub 2011 Aug 23. J Matern Fetal Neonatal Med. 2012. PMID: 21740317
50 results